In addition to potential applications of STAT6 inhibitors in TH2-driven diseases, they may also be useful to prevent excessive inflammatory responses in viral infection or treat autoimmune disease by increasing adenosine signaling. This evidence concerns the gene STAT6 and viral infectious disease.